Faeth Therapeutics, Inc.
FTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001829802
In the last 90 days, Faeth Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $333.8M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Faeth Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- +20 vs. Q4 2025
- Shares held
- 2.16M
- +2.11M (+4,369.6%) vs. Q4 2025
- Total value
- $68.0M
- +$67.5M (+13,104.0%) vs. Q4 2025
- New holders
- 22
- 3 more added
- Sold out
- 2
- 1 more reduced
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $333.8M |
| Q1 2026 | 30 | $68.0M |
| Q4 2025 | 10 | $514.8K |
| Q3 2025 | 9 | $466.2K |
| Q2 2025 | 10 | $600.0K |
| Q1 2025 | 20 | $760.2K |
| Q4 2024 | 24 | $1.16M |
| Q3 2024 | 19 | $1.32M |
| Q2 2024 | 24 | $1.31M |
| Q1 2024 | 25 | $2.43M |
| Q4 2023 | 24 | $2.05M |
| Q3 2023 | 23 | $2.38M |
| Q2 2023 | 26 | $3.58M |
| Q1 2023 | 27 | $4.71M |
| Q4 2022 | 28 | $3.93M |
| Q3 2022 | 31 | $4.47M |
| Q2 2022 | 40 | $7.06M |
| Q1 2022 | 43 | $8.21M |
| Q4 2021 | 38 | $19.7M |
| Q3 2021 | 42 | $37.1M |
| Q2 2021 | 34 | $22.7M |
| Q1 2021 | 40 | $45.8M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Faeth Therapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vivo Capital, LLC | 722,020 | $22.8M | 1.89% | +722,020 | New |
| Cormorant Asset Management, LP | 306,222 | $9.65M | 0.49% | +306,222 | New |
| Millennium Management LLC | 146,565 | $4.62M | 0.00% | +146,565 | New |
| Franklin Resources Inc | 133,506 | $4.21M | 0.00% | +133,506 | New |
| StemPoint Capital LP | 132,873 | $4.19M | 0.81% | +132,873 | New |
| Caligan Partners LP | 126,002 | $3.97M | 0.28% | +126,002 | New |
| Trails Edge Capital Partners, LP | 125,000 | $3.94M | 0.93% | +125,000 | New |
| Marshall Wace, LLP | 65,730 | $2.07M | 0.00% | +65,730 | New |
| Goldman Sachs Group Inc | 61,568 | $1.94M | 0.00% | +61,568 | New |
| HRT Financial LP | 58,001 | $1.83M | 0.00% | +58,001 | New |
| Suvretta Capital Management, LLC | 34,549 | $1.09M | 0.03% | +34,549 | New |
| Bank of America Corp | 33,025 | $1.04M | 0.00% | +32,719+10,692.5% | Added |
| Renaissance Technologies LLC | 32,041 | $1.01M | 0.00% | +20,525+178.2% | Added |
| Logos Global Management LP | 30,000 | $945.6K | 0.05% | +30,000 | New |
| Boothbay Fund Management, LLC | 26,124 | $823.4K | 0.02% | +26,124 | New |
| Brevan Howard Capital Management LP | 20,333 | $640.9K | 0.01% | +20,333 | New |
| Fred Alger Management, LLC | 18,337 | $578.0K | 0.00% | +18,337 | New |
| Balyasny Asset Management LLC | 16,205 | $510.8K | 0.00% | +16,205 | New |
| Catalio Capital Management, LP | 14,718 | $463.9K | 0.10% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 9,501 | $299.5K | 0.00% | +9,501 | New |
| Jane Street Group, LLC | 8,872 | $279.6K | 0.00% | +8,872 | New |
| Morgan Stanley | 8,795 | $277.2K | 0.00% | +8,785+87,850.0% | Added |
| Vanguard Capital Management LLC | 7,750 | $244.3K | 0.00% | +7,750 | New |
| Ikarian Capital, LLC | 6,351 | $200.2K | 0.03% | −15,000−70.3% | Reduced |
| Vanguard Fiduciary Trust Co | 6,307 | $198.8K | 0.00% | +6,307 | New |
| UBS Group AG | 4,529 | $142.8K | 0.00% | +4,529 | New |
| Tower Research Capital LLC (TRC) | 1,496 | $47.2K | 0.00% | +1,496 | New |
| JPMorgan Chase & Co | 32 | $804 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 9 | $284 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 4 | $126 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 0 | $0 | 0.00% | −294−100.0% | Sold out |
| BNP Paribas | 0 | $0 | 0.00% | −7−100.0% | Sold out |